Consensus or Controversy? Investigator Perspectives on Practical Issues and Research Questions in Non-Hodgkin Lymphoma Consensus or Controversy?
Consensus or Controversy? Investigator Perspectives on Practical Issues and Research Questions in Multiple MyelomaConsensus or Controversy?
ASHMM14
TARGET AUDIENCE This activity is intended for hematologists, medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of multiple myeloma (MM). OVERVIEW OF ACTIVITY CNS Tumor Panel and Journal Club: Clinical Investigators Provide Perspectives on Current Cases and Key Presentations and PublicationsCNS Tumor Panel and Journal Club:
5MJCASH2014OVERVIEW OF ACTIVITY
Each year, thousands of clinicians, basic scientists and other industry professionals sojourn to major international oncology conferences, like the American Society of Hematology (ASH) annual meeting, to hone their skills, network with colleagues and learn about recent advances altering state-of-the-art management in hematologic oncology. As such, these events have become global stages where exciting science, cutting-edge concepts and practice-changing data emerge on a truly grand scale. This massive outpouring of information has enormous benefits for the hematologic oncology community, but the truth is it also creates a major challenge for practicing oncologists and hematologists.  |
